May 20, 2025

LDV Capital's Annual General Meeting 2025: The Visual Tech & AI Experts Building The Future

May 20, 2025/ Kat Lopez

We are thrilled to share a few photographs and stories from this year’s invite-only Annual General Meeting – a special event where our LPs connect in person with our team, portfolio companies and experts.

It was a pleasure to host entrepreneurs, investors, researchers and special guests such as Maria Gotsch, Andy Parsons, Brian Cohen, Mark Kalow, Fernando De La Torre, Kristin Dana, Carlos Bhola, Thomas Knox, Matthew Zeiler, Rebekah Griesenauer, Hani Eskandari, Omar Issa, Rebecca Paoletti, Robert Levitan, Andres Glusman, Seth Haberman, Kelly Hoey, Medha Vedaprakash, Emi Gal, Adam Maher, Summer Bedard, Dave Zohrob, Dawn Barber, Jeremiah Robison and many more!

Our Annual General Meeting was a true highlight – full of thoughtful conversations, valuable insights and genuine connection. We’re grateful to everyone who joined us and contributed to making it a success!

January 23, 2025

Partnering With Brilliant People, Delivering Distributions, Recruiting An Analyst & Hopefully Improving Our World

January 23, 2025/ Evan nisselson

We are thrilled to share that we have returned our LDV Capital I & II funds. We continue to have significant upside potential across each of our funds thanks to our brilliant entrepreneurs, experts, team and LP partners.

We continue investing out of our LDV Capital IV fund.

LPs say we are highly differentiated, disciplined, have high-quality sourcing and successfully create value by investing in category leaders at the earliest stages.

We are excited to be recruiting an Analyst to join our team to help us identify, analyze and evaluate investment opportunities. You will be a major contributor to all aspects of our fund from sourcing, market research, due diligence and supporting our portfolio companies.

November 01, 2024

Drug Discoverer Shares Opportunities in Therapeutics & AI

November 01, 2024/ Kat Lopez

Dr. David Rabuka is a serial biotech entrepreneur and investor based in Berkeley California. His expertise is concentrated on translating new technologies into clinical therapies. In 2024, Dr. Rabuka spoke about investment trends & opportunities in life sciences and biotech at our Annual General Meeting. Check out our shortened & lightly edited transcript.

July 29, 2024

Meta’s Matt Uyttendaele on AI for Material Discovery

July 29, 2024/ Kat Lopez

Matt Uyttendaele is the director of the AI for Chemistry group at Meta. His group applies machine learning to material discovery for several applications: clean hydrogen, sorbents for direct air capture, and next-generation displays. In 2024, we were honored to have him speak at our Annual General Meeting about a new application of AI that he has been working on for the last few years and how it relates to his career in visual technologies.

June 07, 2024

LDV Capital's Annual General Meeting 2024: The Visual Tech & AI Experts Building The Future

June 07, 2024/ Kat Lopez

Our Annual General Meetings (AGM) are exclusive, invite-only events for LDV Capital LPs, portfolio companies, LDV experts and special guests. We are thrilled to share a glimpse of our most recent AGM in New York City, giving you a unique opportunity to see what usually happens behind closed doors.

June 15, 2023

LDV Capital's Annual General Meeting 2023: The Visual Tech & AI Experts Building The Future

June 15, 2023/ Kat Lopez

Our Annual General Meetings are invite-only exclusive gatherings that bring together our investors, experts, special guests and portfolio companies. For the first time, we have made the decision to share a few photographs from our most recent Annual General Meeting hosted in New York City to give you a glimpse into what it is like to be a part of our LDV Capital Inner Circle.

LDV Blog